Gut bacteria, previously considered benign, has the ability to alter the immune system of mice enough to affect the rate of Multiple Sclerosis occurance.
Computational models of axonal properties suggest that problems associated with MS, and other demyelinating diseases, may be due more to an imbalance between sodium channels and potassium channels that play a role in the leak current in neuronal membranes, than to the currently targeted sodium channels of most MS drugs.
Scientists at the Keck School of Medicine of USC grow brain cells from skin Oncogenes are generally thought to be...
Radiology researchers at The University of Texas Health Science Center at Houston (UTHealth) have found evidence that multiple sclerosis affects...
Proof of principle study suggests the age-associated decline of the remyelination process is reversible New research highlights the possibility of...
For the first time ever, stem cells from umbilical cords have been converted into other types of cells, which may...
Our bodies are full of tiny superheroes—antibodies that fight foreign invaders, cells that regenerate, and structures that ensure our systems...
A team of scientists from The Scripps Research Institute, collaborating with members of the drug discovery company Receptos, has created...
Controlled trial shows improved spasticity, reduced pain after smoking medical marijuana. A clinical study of 30 adult patients with multiple...
A receptor recently discovered to control the movement of immune cells across the blood-brain barrier may hold the key to...
The biological role of a gene variant implicated in multiple sclerosis (MS) has been determined by researchers at Oxford University. The researchers investigated one particular genetic variant - found in a gene called TNFRSF1A - which has previously been associated with the risk of developing MS.
A new research study conducted has found that the herbal supplement Ginkgo biloba does not improve cognitive function in patients with Multiple Sclerosis (MS.)
